We are live on ! Find out more
RhumbLine Advisers

RhumbLine Advisers Portfolio holdings

AUM $117B
1-Year Est. Return 29.66%
This Fund
S&P 500
This Quarter Est. Return
+8.96%
1 Year Est. Return
+29.66%
3 Year Est. Return
+101.47%
5 Year Est. Return
+137.35%
10 Year Est. Return
+530.92%
AUM
$73.6B
AUM Growth
+$1.15B
Cap. Flow
-$3.6B
Cap. Flow %
-4.89%
Top 10 Hldgs %
20.8%
Holding
3,102
New
50
Increased
790
Reduced
2,114
Closed
100

Top Buys

Rank Stock Value
1
NXPI icon
NXP Semiconductors
NXPI
+$38.7M
2
IFF icon
International Flavors & Fragrances
IFF
+$27.4M
3
NBIX icon
Neurocrine Biosciences
NBIX
+$14.7M
4
COP icon
ConocoPhillips
COP
+$14.5M
5
RPRX icon
Royalty Pharma
RPRX
+$9.46M

Top Sells

Rank Stock Value
1
AAPL icon
Apple
AAPL
+$269M
2
MSFT icon
Microsoft
MSFT
+$172M
3
AMZN icon
Amazon
AMZN
+$114M
4
DIS icon
Walt Disney
DIS
+$62.4M
5
GOOG icon
Alphabet (Google) Class C
GOOG
+$61.8M

Sector Composition

Rank Sector Weight
1 Technology 22.61%
2 Financials 14.26%
3 Healthcare 12.86%
4 Consumer Discretionary 12.27%
5 Industrials 9.79%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
GTT
2951
DELISTED
GTT Communications, Inc.
GTT
$84K ﹤0.01%
45,844
+10
+0% +$30
STEX
2952
Streamex Corp
STEX
$83M
$83K ﹤0.01%
1,921
+100
+5% +$4.67K
SBBP
2953
DELISTED
Strongbridge Biopharma plc.
SBBP
$82K ﹤0.01%
29,836
+100
+0.3% +$302
CFRX
2954
DELISTED
ContraFect Corporation
CFRX
$82K ﹤0.01%
213
-21
-9% -$9.06K
KRMD icon
2955
KORU Medical Systems
KRMD
$164M
$81K ﹤0.01%
23,016
+100
+0.4% +$433
TRAK icon
2956
ReposiTrak
TRAK
$159M
$80K ﹤0.01%
13,162
– –
AVTX icon
2957
Avalo Therapeutics
AVTX
$983M
$77K ﹤0.01%
9
– –
ETON icon
2958
Eton Pharmaceutcials
ETON
$1.22B
$76K ﹤0.01%
10,340
– –
CBUS icon
2959
Cibus
CBUS
$138M
$75K ﹤0.01%
249
– –
CDTX
2960
DELISTED
Cidara Therapeutics
CDTX
$74K ﹤0.01%
1,392
-225
-14% -$11.1K
GNE icon
2961
Genie Energy
GNE
$383M
$72K ﹤0.01%
11,379
– –
VNRX icon
2962
VolitionRx Ltd
VNRX
$9.34M
$71K ﹤0.01%
946
+57
+6% +$4.89K
AGFS
2963
DELISTED
AgroFresh Solutions Inc
AGFS
$69K ﹤0.01%
34,407
+150
+0.4% +$336
SCTL
2964
DELISTED
Societal CDMO, Inc. Common Stock
SCTL
$68K ﹤0.01%
24,196
+100
+0.4% +$359
NYMX
2965
DELISTED
Nymox Pharmaceutical Corp
NYMX
$68K ﹤0.01%
30,467
+100
+0.3% +$264
GALT icon
2966
Galectin Therapeutics
GALT
$348M
$67K ﹤0.01%
30,689
+2,425
+9% +$5.43K
NH
2967
DELISTED
NantHealth, Inc
NH
$66K ﹤0.01%
1,380
+30
+2% +$1.74K
CEMI
2968
DELISTED
Chembio diagnostics, Inc.
CEMI
$63K ﹤0.01%
17,866
– –
ATXS
2969
DELISTED
Astria Therapeutics
ATXS
$61K ﹤0.01%
3,524
– –
LQDA icon
2970
Liquidia Corp
LQDA
$8.02B
$58K ﹤0.01%
21,610
+100
+0.5% +$295
ODT
2971
DELISTED
Odonate Therapeutics, Inc. Common Stock
ODT
$58K ﹤0.01%
17,002
+664
+4% +$12.5K
MRKR icon
2972
Marker Therapeutics
MRKR
$18.7M
$57K ﹤0.01%
2,531
+10
+0.4% +$229
SLNO
2973
DELISTED
Soleno Therapeutics
SLNO
$54K ﹤0.01%
2,840
+102
+4% +$3.29K
LNAI
2974
Lunai Bioworks
LNAI
$10.9M
$53K ﹤0.01%
188
+1
+0.5% +$294
LFWD icon
2975
ReWalk Robotics
LFWD
$21.6M
$53K ﹤0.01%
+262
New +$60.3K
117 118
119
120 121

Similar funds

VAM
Vanguard Asset Management London, Ec4n 8af $117B AUM
Manulife (Manufacturers Life Insurance)
Manulife (Manufacturers Life Insurance) Canada, Ontario, Canada $116B AUM 26.37% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return
DZ Bank
DZ Bank Frankfurt Am Main, Germany $113B AUM 36.92% 1-Year Est. Return
Schroder Investment Management Group
Schroder Investment Management Group London, United Kingdom $122B AUM 29.27% 1-Year Est. Return
National Bank of Canada
National Bank of Canada Montreal, Quebec, Canada $112B AUM 31.26% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return
Stifel Financial
Stifel Financial St. Louis, Missouri $109B AUM 21.36% 1-Year Est. Return

RhumbLine Advisers's Q1 2021 Portfolio in Review

As of Q1 2021, RhumbLine Advisers held 3,102 positions worth $73.6B, up 1.6% from $72.5B the previous quarter. Its ten largest holdings account for 21% of the portfolio.

RhumbLine Advisers withdrew a net $3.6B in Q1 2021, closing 100 positions and reducing 2,114 holdings. Its most notable exit was Tiffany & Co., an estimated $26.8M position sold in full.

By sector, the portfolio is most concentrated in Technology at 23% of assets, down from 24% a quarter earlier, followed by Financials and Healthcare.

Against the trend, RhumbLine Advisers opened a new position in NXP Semiconductors worth $42.7M.

  • RhumbLine Advisers's largest Q1 2021 buy was NXP Semiconductors: 211,843 shares worth $42.7M.
  • RhumbLine Advisers added most to International Flavors & Fragrances in Q1 2021, an estimated $27.4M increase.
  • RhumbLine Advisers's biggest Q1 2021 reduction was Apple, cutting an estimated $269M.
  • RhumbLine Advisers fully exited Tiffany & Co. in Q1 2021, selling an estimated $26.8M.
  • RhumbLine Advisers's ten largest holdings make up 21% of its $73.6B portfolio in Q1 2021.
  • RhumbLine Advisers opened 50 new positions and closed 100 in Q1 2021.
  • RhumbLine Advisers's portfolio value rose 1.6% quarter-over-quarter to $73.6B.

Based on RhumbLine Advisers's 13F filing for Q1 2021, filed 6 May 2021.